NASDAQ · Medical - Healthcare Information Services
HQY (HQY) Stock
$100.93
+1.89%
NASDAQ: HQY
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
HQY: Lowering target price to $104.00
Argus Research · Jul 15, 2026
GDRX or HQY: Which Is the Better Value Stock Right Now?
Zacks · Jul 8, 2026
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Zacks · Jun 12, 2026
Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
Zacks · Jun 11, 2026
The Bull Case For HealthEquity (HQY) Could Change Following Raised Earnings Outlook And Completed Buyback Program
Simply Wall St. · Jun 10, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About HQY
HQY is led by CEO Scott R. Cutler, employs 2,814 people, headquartered in Draper, US, publicly traded since 2014.
HQY stock trades at $100.93 with a market capitalization of $8.44B. The stock is valued at a price-to-earnings (P/E) ratio of 32.71, price-to-book of 3.25, price-to-sales of 5.18. Over the past 52 weeks the stock has ranged between $72.76 and $116.65, and currently trades 13.5% below its 52-week high.
On profitability, HQY generates a return on equity (ROE) of 10.19%, return on capital employed of 7.68%, an operating margin of 21.64%, a net profit margin of 16.38%.